ICRP Publication 53
Radiation Dose to Patients from Radiopharmaceuticals
Series: Annals of the ICRP; 53;
- Publisher's listprice GBP 176.00
-
89 073 Ft (84 832 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 17 815 Ft off)
- Discounted price 71 259 Ft (67 866 Ft + 5% VAT)
89 073 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number and title Annals of the ICRP v. 18/1-4
- Edition number 1
- Publisher SAGE Publications Ltd
- Date of Publication 1 April 1988
- ISBN 9780080355917
- Binding Paperback
- No. of pages380 pages
- Size 250 x 160 mm
- Weight 962 g
- Language English 0
Categories
Short description:
This publication presents biokinetic models and best estimates of biokinetic data for some 120 individual radiopharmaceuticals, giving estimated absorbed doses, including the range of variation to be expected in pathological states, for adults, children and the fetus. Absorbed dose estimates are needed in clinical diagnostic work for judging the risk associated with the use of specific radiopharmaceuticals, both for comparison with the possible benefit of the investigation and to help in giving adequate information to the patient. These estimates provide guidance to ethics committees having to decide upon research projects involving the use of radioactive substances in volunteers who receive no individual benefit from the study. This report, while still an important source document, is supplemented and amended by ICRP Publication 80.
MoreLong description:
This publication presents biokinetic models and best estimates of biokinetic data for some 120 individual radiopharmaceuticals, giving estimated absorbed doses, including the range of variation to be expected in pathological states, for adults, children and the fetus. Absorbed dose estimates are needed in clinical diagnostic work for judging the risk associated with the use of specific radiopharmaceuticals, both for comparison with the possible benefit of the investigation and to help in giving adequate information to the patient. These estimates provide guidance to ethics committees having to decide upon research projects involving the use of radioactive substances in volunteers who receive no individual benefit from the study. This report, while still an important source document, is supplemented and amended by ICRP Publication 80.
More
ICRP Publication 53: Radiation Dose to Patients from Radiopharmaceuticals
Subcribe now and receive a favourable price.
Subscribe
89 073 HUF
